While NovaBay Pharmaceuticals beat earnings estimates, which is generally a positive signal, the company reported lower revenue compared to the same period last year. This mixed result could lead to uncertainty among investors, potentially impacting the stock price. Additionally, the company's previous earnings miss led to a significant drop in share price, which could influence investor sentiment.